BANK OF AMERICA CORP /DE/
BankPosition in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in ZNTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,406,051
+$2,756,484 QoQ
Shares Held
1,114,650
-1.6% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 114 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ZNTL ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ZNTL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,406,051 | 1,114,650 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,649,567 | 1,132,294 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,845,792 | 1,367,254 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,338,658 | 1,548,781 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $827,444 | 713,315 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,796,846 | 1,130,092 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $654,476 | 215,999 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,853,971 | 775,536 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,078,672 | 508,233 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,501,066 | 475,956 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,887,441 | 718,643 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,673,236 | 232,963 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,489,301 | 265,484 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,164,988 | 300,290 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,840,447 | 240,340 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,645,442 | 122,135 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,696,021 | 309,467 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,115,200 | 284,248 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $16,592,517 | 197,389 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,621,149 | 84,351 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,353,196 | 81,827 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $3,928,616 | 90,542 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,496,442 | 48,064 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $978,476 | 29,932 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $813,410 | 16,939 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||